Cargando…
Academic User View: Organ-on-a-Chip Technology
Organ-on-a-Chip (OoC) systems bring together cell biology, engineering, and material science for creating systems that recapitulate the in vivo microenvironment of tissues and organs. The versatility of OoC systems enables in vitro models for studying physiological processes, drug development, and t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869899/ https://www.ncbi.nlm.nih.gov/pubmed/35200386 http://dx.doi.org/10.3390/bios12020126 |
_version_ | 1784656605220962304 |
---|---|
author | Busek, Mathias Aizenshtadt, Aleksandra Amirola-Martinez, Mikel Delon, Ludivine Krauss, Stefan |
author_facet | Busek, Mathias Aizenshtadt, Aleksandra Amirola-Martinez, Mikel Delon, Ludivine Krauss, Stefan |
author_sort | Busek, Mathias |
collection | PubMed |
description | Organ-on-a-Chip (OoC) systems bring together cell biology, engineering, and material science for creating systems that recapitulate the in vivo microenvironment of tissues and organs. The versatility of OoC systems enables in vitro models for studying physiological processes, drug development, and testing in both academia and industry. This paper evaluates current platforms from the academic end-user perspective, elaborating on usability, complexity, and robustness. We surveyed 187 peers in 35 countries and grouped the responses according to preliminary knowledge and the source of the OoC systems that are used. The survey clearly shows that current commercial OoC platforms provide a substantial level of robustness and usability—which is also indicated by an increasing adaptation of the pharmaceutical industry—but a lack of complexity can challenge their use as a predictive platform. Self-made systems, on the other hand, are less robust and standardized but provide the opportunity to develop customized and more complex models, which are often needed for human disease modeling. This perspective serves as a guide for researchers in the OoC field and encourages the development of next-generation OoCs. |
format | Online Article Text |
id | pubmed-8869899 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88698992022-02-25 Academic User View: Organ-on-a-Chip Technology Busek, Mathias Aizenshtadt, Aleksandra Amirola-Martinez, Mikel Delon, Ludivine Krauss, Stefan Biosensors (Basel) Perspective Organ-on-a-Chip (OoC) systems bring together cell biology, engineering, and material science for creating systems that recapitulate the in vivo microenvironment of tissues and organs. The versatility of OoC systems enables in vitro models for studying physiological processes, drug development, and testing in both academia and industry. This paper evaluates current platforms from the academic end-user perspective, elaborating on usability, complexity, and robustness. We surveyed 187 peers in 35 countries and grouped the responses according to preliminary knowledge and the source of the OoC systems that are used. The survey clearly shows that current commercial OoC platforms provide a substantial level of robustness and usability—which is also indicated by an increasing adaptation of the pharmaceutical industry—but a lack of complexity can challenge their use as a predictive platform. Self-made systems, on the other hand, are less robust and standardized but provide the opportunity to develop customized and more complex models, which are often needed for human disease modeling. This perspective serves as a guide for researchers in the OoC field and encourages the development of next-generation OoCs. MDPI 2022-02-16 /pmc/articles/PMC8869899/ /pubmed/35200386 http://dx.doi.org/10.3390/bios12020126 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Perspective Busek, Mathias Aizenshtadt, Aleksandra Amirola-Martinez, Mikel Delon, Ludivine Krauss, Stefan Academic User View: Organ-on-a-Chip Technology |
title | Academic User View: Organ-on-a-Chip Technology |
title_full | Academic User View: Organ-on-a-Chip Technology |
title_fullStr | Academic User View: Organ-on-a-Chip Technology |
title_full_unstemmed | Academic User View: Organ-on-a-Chip Technology |
title_short | Academic User View: Organ-on-a-Chip Technology |
title_sort | academic user view: organ-on-a-chip technology |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869899/ https://www.ncbi.nlm.nih.gov/pubmed/35200386 http://dx.doi.org/10.3390/bios12020126 |
work_keys_str_mv | AT busekmathias academicuservieworganonachiptechnology AT aizenshtadtaleksandra academicuservieworganonachiptechnology AT amirolamartinezmikel academicuservieworganonachiptechnology AT delonludivine academicuservieworganonachiptechnology AT kraussstefan academicuservieworganonachiptechnology |